Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Nutrients ; 15(19)2023 Sep 27.
Artículo en Inglés | MEDLINE | ID: mdl-37836456

RESUMEN

Atopic dermatitis (AD) is a chronic inflammatory disease characterized by dry and itchy skin. Recently, it has been reported that oxidative stress is involved in skin diseases, possibly including AD. Vitamin C, also referred to as ascorbic acid, is a vital water-soluble compound that functions as an essential nutrient. It plays a significant role as both an antioxidant and an additive in various pharmaceutical and food products. Despite the fact that vitamin C is easily oxidized, we have developed NXP081, a single-stranded DNA aptamer that selectively binds to vitamin C, thereby inhibiting its oxidation. The objective of the current research was to examine the impact of NXP081, an animal model of AD induced by 2,4-dinitrofluorobenzene (DNFB). The experimental drug NXP081, when taken orally, showed promising results in reducing inflammation and improving the skin conditions caused by DNFB. The administration of NXP081 resulted in a significant reduction in ear swelling and a noticeable improvement in the appearance of skin lesions. In addition, the administration of NXP081 resulted in a significant decrease in the migration of mast cells in the skin lesions induced by DNFB. Moreover, NXP081 inhibited the production of interferon-gamma (IFN-γ) in CD4+ T cells that were activated and derived from the lymph nodes. Our findings provide useful information about the anti-inflammatory effect of NXP081 on AD.


Asunto(s)
Aptámeros de Nucleótidos , Dermatitis Atópica , Enfermedades de la Piel , Ratones , Animales , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/metabolismo , Dinitrofluorobenceno/efectos adversos , Ratones Endogámicos BALB C , Aptámeros de Nucleótidos/efectos adversos , Ácido Ascórbico/metabolismo , Linfocitos T CD4-Positivos/metabolismo , Enfermedades de la Piel/metabolismo , Vitaminas/farmacología , Piel/metabolismo , Citocinas/metabolismo
2.
Immunopharmacol Immunotoxicol ; 45(1): 114-121, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36066092

RESUMEN

BACKGROUND: Oxidative stress and inflammation are involved in chronic fatigue. Euscaphic acid (EA) is an active compound of Eriobotrya japonica (Loquat) and has anti-oxidative effect. METHODS: The goal of present study is to prove whether EA could relieve fatigue through enhancing anti-oxidant and anti-inflammatory effects in in vitro/in vivo models. RESULTS: EA notably improved activity of superoxide dismutase (SOD) and catalase (CAT), while EA reduced levels of malondiadehyde (MDA) and inflammatory cytokines without cytotoxicity in H2O2-stimulated in myoblast cell line, C2C12 cells. EA significantly reduced levels of fatigue-causing factors such as lactate dehydrogenase (LDH) and creatin kinase (CK), while EA significantly incresed levels of anti-fatigue-related factor, glycogen compared to the H2O2-stimulated C2C12 cells. In treadmill stress test (TST), EA significantly enhanced activities of SOD and CAT as well as exhaustive time and decreased levels of MDA and inflammatory cytokines. After TST, levels of free fatty acid, citrate synthase, and muscle glycogen were notably enhanced by oral administration of EA, but EA decreased levels of lactate, LDH, cortisol, aspartate aminotransferase, alanine transaminase, CK, glucose, and blood urea nitrogen compared to the control group. Furthermore, in forced swimming test, EA significantly increased levels of anti-fatigue-related factors and decreased excessive accumulations of fatigue-causing factors. CONCLUSIONS: Therefore, the results indicate that potent anti-fatigue effect of EA can be achieved via the improvement of anti-oxidative and anti-inflammatory properties, and this study will provide scientific data for EA to be developed as a novel and efficient component in anti-fatigue health functional food.


Asunto(s)
Peróxido de Hidrógeno , Estrés Oxidativo , Glucógeno/metabolismo , Glucógeno/farmacología , Creatina Quinasa , Superóxido Dismutasa/metabolismo
3.
Molecules ; 24(6)2019 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-30901980

RESUMEN

Crotonaldehyde is an extremely toxic α,ß-unsaturated aldehyde found in cigarette smoke, and it causes inflammation and vascular dysfunction. Autophagy has been reported to play a key role in the pathogenesis of vascular diseases. However, the precise mechanism underlying the role of acute exposure crotonaldehyde in vascular disease development remains unclear. In the present study, we aimed to investigate the effect of crotonaldehyde-induced autophagy in endothelial cells. Acute exposure to crotonaldehyde decreased cell viability and induced autophagy followed by cell death. In addition, inhibiting the autophagic flux markedly promoted the viability of endothelial cells exposed to high concentrations of crotonaldehyde. Crotonaldehyde activated the AMP-activated protein kinase (AMPK) and p38 mitogen-activated protein kinase (MAPK) pathways, and pretreatment with inhibitors specific to these kinases showed autophagy inhibition and partial improvement in cell viability. These data show that acute exposure to high concentrations of crotonaldehyde induces autophagy-mediated cell death. These results might be helpful to elucidate the mechanisms underlying crotonaldehyde toxicity in the vascular system and contribute to environmental risk assessment.


Asunto(s)
Aldehídos/farmacología , Autofagia/efectos de los fármacos , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Proteínas Quinasas Activadas por AMP/metabolismo , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Humanos , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal/efectos de los fármacos , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
4.
J Pharmacol Exp Ther ; 367(2): 215-221, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30135179

RESUMEN

The cytotoxic drugs used in chemotherapy are often accompanied by nausea and vomiting. Despite the use of antiemetic drugs, chemotherapy-induced nausea and vomiting (CINV) remain significant side effects for cancer patients and are associated with serotonin type 3 receptor (5-HT3R) activation in the brainstem. Farnesol and nerolidol are sesquiterpene alcohols found in essential oils of plants such as roses, citronella, and lemon grass and are used as antiemetic parapheromones. Medicinal plants often are effective in treating gastrointestinal disorders, including CINV, although the mechanism of action remains unclear. In the current work, the antiemetic efficacy of the naturally occurring racemic mixture of farnesol (m-farnesol) and nerolidol (m-nerolidol) against cisplatin CINV was tested using the pica behavior (consumption of nonnutritive substances) of rats. Animals treated with m-farnesol or m-nerolidol consumed a smaller amount of kaolin than of saline-treated control animals. This result is consistent with the antiemetic efficacy of farnesol and nerolidol. Compared with controls, m-farnesol- but not m-nerolidol-treated animals consumed more food and lost less body weight. Thus, farnesol effectively reduced appetite suppression and weight loss induced by cisplatin. In separate experiments, isomers of farnesol and nerolidol were tested on 5-HT-induced responses of acutely isolated nodose neurons using patch-clamp methods. All the tested constituents inhibited 5-HT3R-mediated current in a noncompetitive manner. Thus, both farnesol and nerolidol may exert antiemetic efficacy by inhibiting 5-HT signaling in cranial visceral afferents, resulting in interruption of emetogenic signaling; however, nerolidol failed to suppress cisplatin-induced anorexia and weight loss, suggesting that additional mechanisms may contribute.


Asunto(s)
Antieméticos/farmacología , Antineoplásicos/efectos adversos , Náusea/tratamiento farmacológico , Vómitos/tratamiento farmacológico , Animales , Apetito/efectos de los fármacos , Cisplatino/efectos adversos , Farnesol/farmacología , Masculino , Náusea/inducido químicamente , Aceites Volátiles/farmacología , Pica/tratamiento farmacológico , Ratas , Ratas Wistar , Receptores de Serotonina 5-HT3/metabolismo , Sesquiterpenos/farmacología , Vómitos/inducido químicamente , Pérdida de Peso/efectos de los fármacos
5.
Chem Pharm Bull (Tokyo) ; 63(12): 1076-80, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26633030

RESUMEN

The aim of this study was to search for a novel choline acetyltransferase (ChAT) activator from plants traditionally grown in Korea. An ethanol extract from Chaenomeles sinensis Koehne showed the highest ChAT-activating effect in vitro in an assay that used human neuroblastoma cells and [(14)C]acetyl-CoA. The active compound was speculated to be stearic acid methyl ester (SAME). In an in vivo experiment, C. sinensis extract and SAME improved trimethyltin (TMT)-induced deficits in learning and memory in mice as assessed by a Y-maze behavioral test and a passive avoidance test. The C. sinensis extract might attenuate the TMT-induced brain disorder. This study suggests that SAME from C. sinensis might be useful in the treatment of Alzheimer's disease.


Asunto(s)
Colina O-Acetiltransferasa/metabolismo , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/tratamiento farmacológico , Neuroblastoma/metabolismo , Extractos Vegetales/farmacología , Rosaceae/química , Animales , Línea Celular Tumoral , Activación Enzimática/efectos de los fármacos , Humanos , Masculino , Trastornos de la Memoria/inducido químicamente , Ratones , Ratones Endogámicos ICR , Neuroblastoma/enzimología , Neuroblastoma/patología , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Compuestos de Trimetilestaño/farmacología
6.
J Anal Methods Chem ; 2015: 916346, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26550520

RESUMEN

Few studies have investigated Seomae mugwort (a Korean native mugwort variety of Artemisia argyi H. Lév. & Vaniot), exclusively cultivated in the southern Korean peninsula, and the possibility of its use as a food resource. In the present study, we compared the nutritional and chemical properties as well as sensory attributes of Seomae mugwort and the commonly consumed species Artemisia princeps Pamp. In comparison with A. princeps, Seomae mugwort had higher contents of polyunsaturated fatty acids, total phenolic compounds, vitamin C, and essential amino acids. In addition, Seomae mugwort had better radical scavenging activity and more diverse volatile compounds than A. princeps as well as favorable sensory attributes when consumed as tea. Given that scant information is available regarding the Seomae mugwort and its biological, chemical, and sensory characteristics, the results herein may provide important characterization data for further industrial and research applications of this mugwort variety.

7.
Int J Mol Sci ; 16(7): 14526-39, 2015 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-26132561

RESUMEN

The pathophysiology of cardiovascular diseases is complex and may involve oxidative stress-related pathways. Eriodictyol is a flavonoid present in citrus fruits that demonstrates anti-inflammatory, anti-cancer, neurotrophic, and antioxidant effects in a range of pathophysiological conditions including vascular diseases. Because oxidative stress plays a key role in the pathogenesis of cardiovascular disease, the present study was designed to verify whether eriodictyol has therapeutic potential. Upregulation of heme oxygenase-1 (HO-1), a phase II detoxifying enzyme, in endothelial cells is considered to be helpful in cardiovascular disease. In this study, human umbilical vein endothelial cells (HUVECs) treated with eriodictyol showed the upregulation of HO-1 through extracellular-regulated kinase (ERK)/nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathways. Further, eriodictyol treatment provided protection against hydrogen peroxide-provoked cell death. This protective effect was eliminated by treatment with a specific inhibitor of HO-1 and RNA interference-mediated knockdown of HO-1 expression. These data demonstrate that eriodictyol induces ERK/Nrf2/ARE-mediated HO-1 upregulation in human endothelial cells, which is directly associated with its vascular protection against oxidative stress-related endothelial injury, and propose that targeting the upregulation of HO-1 is a promising approach for therapeutic intervention in cardiovascular disease.


Asunto(s)
Elementos de Respuesta Antioxidante , Antioxidantes/farmacología , Flavanonas/farmacología , Hemo-Oxigenasa 1/metabolismo , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo , Muerte Celular , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Hemo-Oxigenasa 1/genética , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Humanos , Peróxido de Hidrógeno/toxicidad , Factor 2 Relacionado con NF-E2/genética , Regulación hacia Arriba
8.
J Invest Dermatol ; 135(11): 2705-2713, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26099025

RESUMEN

Atopic dermatitis (AD) is a common multifactorial chronic skin disease that has a multiple and complex pathogenesis. AD is gradually increasing in prevalence globally. In NC/Nga mice, repetitive applications of 2, 4-dinitrofluorobenzene (DNFB) evoke AD-like clinical symptoms similar to human AD. Aspartame (N-L-α-aspartyl-L-phenylalanine 1-methyl ester) is a methyl ester of a dipeptide, which is used as an artificial non-nutritive sweetener. Aspartame has analgesic and anti-inflammatory functions that are similar to the function of nonsteroidal anti-inflammatory drugs such as aspirin. We investigated whether aspartame can relieve AD-like clinical symptoms induced by DNFB treatment in NC/Nga mice. Sucrose did not relieve AD-like symptoms, whereas aspartame at doses of 0.5 µg kg(-1) and 0.5 mg kg(-1) inhibited ear swelling and relieved AD-like clinical symptoms. Aspartame inhibited infiltration of inflammatory cells including eosinophils, mast cells, and CD4(+) T cells, and suppressed the expression of cytokines including IL-4 and IFN-γ, and total serum IgE levels. Aspartame may have therapeutic value in the treatment of AD.


Asunto(s)
Aspartame/administración & dosificación , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/patología , Dinitrofluorobenceno/farmacología , Flavanonas , Análisis de Varianza , Animales , Biopsia con Aguja , Citocinas/efectos de los fármacos , Citocinas/metabolismo , Dermatitis Atópica/inducido químicamente , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Humanos , Inmunoglobulina E/efectos de los fármacos , Inmunoglobulina E/metabolismo , Inmunohistoquímica , Masculino , Ratones , Distribución Aleatoria
9.
J Cardiovasc Pharmacol ; 66(1): 108-17, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25815672

RESUMEN

Consumption of omega-3 polyunsaturated fatty acid, particularly eicosapentaenoic acid (EPA), is associated with a significant reduction in the risk of developing cardiovascular disease. The aim of this study was to investigate whether heme oxygenase-1 (HO-1) induction contributes to the cytoprotective effects of EPA in endothelial cells threatened with oxidative damage. In this study, we investigated the effect of EPA on the induction of HO-1 by NF-E2-related factor 2 (Nrf2) in human umbilical vein endothelial cells. In cells treated with low concentrations of EPA (10-25 µM), HO-1 expression increased in a time- and concentration-dependent manner. Additionally, EPA treatment increased Nrf2 nuclear translocation and antioxidant response element activity, leading to the upregulation of HO-1 expression. Furthermore, treatment with EPA reduced hydrogen peroxide (H(2)O(2))-induced cell death. The reduction in cell death was reversed by treatment with zinc protoporphyrin, an inhibitor of HO-1, indicating that HO-1 contributed to the protective effect of EPA. These data suggest that EPA protects against H(2)O(2)-induced oxidative stress in endothelial cells by activating Nrf2 and inducting HO-1 expression.


Asunto(s)
Citoprotección/fisiología , Ácido Eicosapentaenoico/farmacología , Hemo-Oxigenasa 1/fisiología , Células Endoteliales de la Vena Umbilical Humana/fisiología , Factor 2 Relacionado con NF-E2/fisiología , Citoprotección/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Humanos
10.
Appl Microbiol Biotechnol ; 99(5): 2083-92, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25620368

RESUMEN

Rosmarinic acid (α-o-caffeoyl-3,4-dihydroxyphenyllactic acid; RA) is a naturally occurring hydroxylated compound commonly found in species of the subfamily Nepetoideae of the Lamiaceae and Boraginaceae, such as Rosmarinus officinalis, Salvia officinalis, and Perilla frutescens. RA is biosynthesized from the amino acids L-phenylalanine and L-tyrosine by eight enzymes that include phenylalanine ammonia lyase and cinnamic acid 4-hydroxylase. RA can also be chemically produced by the esterification of caffeic acid and 3,4-dihydroxyphenyllactic acid. RA and its numerous derivatives containing one or two RA with other aromatic moieties are well known and include lithospermic acid, yunnaneic acid, salvianolic acid, and melitric acid. Recently, RA and its derivatives have attracted interest for their biological activities, which include anti-inflammatory, anti-oxidant, anti-angiogenic, anti-tumor, and anti-microbial functions. Clinically, RA attenuates T cell receptor-mediated signaling, attenuates allergic diseases like allergic rhinitis and asthma, and 2,4-dinitrofluorobenzene-induced atopic dermatitis-like symptoms, protects from neurotoxicity, and slows the development of Alzheimer's disease. These attributes have increased the demand for the biotechnological production and application of RA and its derivatives. The present review discusses the function and application of RA and its derivatives including the molecular mechanisms underlying clinical efficacy.


Asunto(s)
Vías Biosintéticas , Biotecnología/métodos , Cinamatos/metabolismo , Depsidos/metabolismo , Factores Inmunológicos/metabolismo , Cinamatos/síntesis química , Depsidos/síntesis química , Factores Inmunológicos/química , Perilla frutescens/metabolismo , Rosmarinus/metabolismo , Salvia officinalis/metabolismo , Tecnología Farmacéutica/métodos , Ácido Rosmarínico
11.
Biochem Biophys Res Commun ; 456(1): 167-72, 2015 Jan 02.
Artículo en Inglés | MEDLINE | ID: mdl-25446121

RESUMEN

Gastrointestinal disorder is a common symptom induced by diverse pathophysiological conditions that include food tolerance, chemotherapy, and irradiation for therapy. Prostaglandin E2 (PGE2) level increase was often reported during gastrointestinal disorder and prostaglandin synthetase inhibitors has been used for ameliorate the symptoms. Exogenous administration of PGE2 induces gastrointestinal disorder, however, the mechanism of action is not known. Therefore, we tested PGE2 effect on visceral afferent sensory neurons of the rat. Interestingly, PGE2 itself did not evoked any response but enhanced serotonin (5-HT)-evoked currents up to 167% of the control level. The augmented 5-HT responses were completely inhibited by a 5-HT type 3 receptor antagonist, ondansetron. The PGE2-induced potentiation were blocked by a selective E-prostanoid type 4 (EP4) receptors antagonist, L-161,982, but type 1 and 2 receptor antagonist AH6809 has no effect. A membrane permeable protein kinase A (PKA) inhibitor, KT5720 also inhibited PGE2 effects. PGE2 induced 5-HT current augmentation was observed on 15% and 21% of the stomach and ileum projecting neurons, respectively. Current results suggest a synergistic signaling in visceral afferent neurons underlying gastrointestinal disorder involving PGE2 potentiation of 5-HT currents. Our findings may open a possibility for screen a new type drugs with lower side effects than currently using steroidal prostaglandin synthetase inhibitors by selectively targeting EP4 receptor/PKA pathway without interrupt prostaglandin synthesis.


Asunto(s)
Dinoprostona/farmacología , Íleon/efectos de los fármacos , Ganglio Nudoso/efectos de los fármacos , Células Receptoras Sensoriales/metabolismo , Serotonina/metabolismo , Estómago/efectos de los fármacos , Aferentes Viscerales/metabolismo , Animales , Antiinflamatorios/farmacología , Carbazoles/farmacología , Relación Dosis-Respuesta a Droga , Enfermedades Gastrointestinales/tratamiento farmacológico , Íleon/inervación , Masculino , Neuronas Aferentes/metabolismo , Ondansetrón/farmacología , Técnicas de Placa-Clamp , Prostaglandinas/metabolismo , Pirroles/farmacología , Ratas , Ratas Sprague-Dawley , Receptores de Serotonina 5-HT3/metabolismo , Transducción de Señal , Estómago/inervación , Tiofenos/farmacología , Triazoles/farmacología , Xantonas/farmacología
12.
J Biomed Mater Res A ; 103(5): 1809-17, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25231265

RESUMEN

Bacterial cellulose (BC) has been studied widely for applications in biomedical materials such as prosthetic artificial blood vessels owing to its unique characteristics, which include nontoxicity and nonimmunogenicity as compared with synthetic biopolymers such as expanded polytetrafluorethylene (ePTFE). However, to date, studies on the relative effect of leukocytes on BC as a prosthetic vascular graft are insufficient. Polymorphonuclear leukocytes (PMN) play a pivotal role in early-phase immune response to bacterial or periprosthetic infection. PMN recruitment at sites of infection or inflammation mediated by various integrins such as ß2 integrin family (CD11/CD18 family). Therefore, we discuss our investigations into the mechanisms by which ß2 integrins-mediated chemosensory adhesion and migration of PMN on the vascular graft surface, BC. Our results show that CD11b/CD18 components mainly mediate PMN adherence on BC. CD11b/CD18 displays weak coordination with the other two α subunits (CD11a and CD11c). Furthermore, it was found that the ß subunit (CD18) plays a critical role in both the adhesion and migration of N-formylmethionyl-leucyl-phenylalanine (fMLP)-stimulated PMN on BC. The activity of CD18 contrasts with that of the individual α subunits. Among these, only CD11b displayed inhibition of PMN migration on BC surfaces.


Asunto(s)
Antígenos CD18/metabolismo , Movimiento Celular/efectos de los fármacos , Celulosa/farmacología , Gluconacetobacter xylinus/química , Neutrófilos/citología , Neutrófilos/metabolismo , Adhesión Celular/efectos de los fármacos , Recuento de Células , Humanos , Microscopía Fluorescente , N-Formilmetionina Leucil-Fenilalanina/farmacología , Neutrófilos/efectos de los fármacos
13.
J Med Food ; 17(11): 1222-31, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25133313

RESUMEN

Alzheimer's disease (AD) is pathologically characterized by the presence of amyloid plaques in brain and the overproduction of amyloid beta (Aß), leading to learning and memory impairment and intense oxidative stress. In this study, the protective effect of Ligularia fischeri extract was investigated using PC12 cells. L. fischeri extract attenuated hydrogen-peroxide-induced DNA fragmentation in cells. In vivo behavioral tests were performed to examine the effects of the extract on amyloid-ß peptide1-42-induced impairment of learning and memory in mice. A diet containing the extract increased alternation behaviors in the Y-maze test and step-through latency of passive avoidance task. Moreover, we found that consumption of the extract decreased lipid peroxidation in a biochemical study of brain tissue in mice. High-performance liquid chromatography was used to identify the active compounds in the extract. These results suggest that L. fischeri extract could be protective against Aß-induced neurotoxicity, possibly due to the antioxidative capacity of its constituent, 3-O-caffeoylquinic acid.


Asunto(s)
Péptidos beta-Amiloides/metabolismo , Antioxidantes/uso terapéutico , Asteraceae/química , Encéfalo/efectos de los fármacos , Fragmentación del ADN/efectos de los fármacos , Síndromes de Neurotoxicidad/prevención & control , Estrés Oxidativo/efectos de los fármacos , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/prevención & control , Péptidos beta-Amiloides/toxicidad , Animales , Antioxidantes/farmacología , Reacción de Prevención/efectos de los fármacos , Ácido Clorogénico/farmacología , Ácido Clorogénico/uso terapéutico , Trastornos del Conocimiento/inducido químicamente , Trastornos del Conocimiento/genética , Trastornos del Conocimiento/prevención & control , Peróxido de Hidrógeno/metabolismo , Peróxido de Hidrógeno/toxicidad , Discapacidades para el Aprendizaje/inducido químicamente , Discapacidades para el Aprendizaje/prevención & control , Peroxidación de Lípido/efectos de los fármacos , Masculino , Memoria/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/prevención & control , Ratones Endogámicos ICR , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Síndromes de Neurotoxicidad/genética , Células PC12 , Fitoterapia , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas
14.
Korean J Physiol Pharmacol ; 18(2): 149-53, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24757377

RESUMEN

Nausea and emesis are a major side effect and obstacle for chemotherapy in cancer patients. Employ of antiemetic drugs help to suppress chemotherapy-induced emesis in some patients but not all patients. Ginger, an herbal medicine, has been traditionally used to treat various kinds of diseases including gastrointestinal symptoms. Ginger is effective in alleviating nausea and emesis, particularly, for cytotoxic chemotherapy drug-induced emesis. Ginger-mediated antiemetic effect has been attributed to its pungent constituents-mediated inhibition of serotonin (5-HT) receptor activity but its cellular mechanism of action is still unclear. Emetogenic chemotherapy drugs increase 5-HT concentration and activate visceral vagal afferent nerve activity. Thus, 5-HT mediated vagal afferent activation is essential to provoke emesis during chemotherapy. In this experiment, water extract of ginger and its three major pungent constituent's effect on 5-HT-evoked responses were tested on acutely dispersed visceral afferent neurons with patch-clamp methods. The ginger extract has similar effects to antiemetic drug ondansetron by blocking 5-HT-evoked responses. Pungent constituents of the ginger, [6]-shogaol, [6]-gingerol, and zingerone inhibited 5-HT responses in a dose dependent manner. The order of inhibitory potency for these compounds were [6]-shogaol>[6]-gingerol>zingerone. Unlike well-known competitive 5-HT3 receptor antagonist ondansetron, all tested ginger constituents acted as non-competitive antagonist. Our results imply that ginger and its pungent constituents exert antiemetic effects by blocking 5-HT-induced emetic signal transmission in vagal afferent neurons.

15.
Food Chem Toxicol ; 66: 341-9, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24525099

RESUMEN

Atopic dermatitis (AD) is a multifactorial chronic skin disorder that is increasing in prevalence globally. In NC/Nga mice, repetitive epicutaneous applications of 2-4-dinitrofluorobenzene (DNFB) induces AD-like clinical symptoms. Bioflanonol fisetin (3,7,3',4'-tetrahydroxyflavone) is a dietary component found in plants, fruits and vegetables. Fisetin has various physiological effects that include anti-oxidation, anti-angiogenesis, anti-carcinogenesis and anti-inflammation. In this study, we investigated whether fisetin relieves AD-like clinical symptoms induced by repeated DNFB treatment in NC/Nga mice. Fisetin significantly inhibited infiltration of inflammatory cells including eosinophils, mast cells and CD4(+) T and CD8(+) T cells, and suppressed the expressions of cytokines and chemokines associated with dermal infiltrates in AD-like skin lesions. Total serum immunoglobulin E (IgE) levels and the ratio of phospho-NF-κB p65 to total NF-κB p65 were markedly reduced by fisetin. Fisetin also reduced the production of interferon-gamma and interleukin-4 by activated CD4(+) T cells in a dose-dependent manner, whereas the anti-inflammatory cytokine, interleukin-10 was increased. These results implicate fisetin as a potential therapeutic for AD.


Asunto(s)
Dermatitis Atópica/etiología , Dinitrofluorobenceno/toxicidad , Flavonoides/farmacología , Inmunosupresores/farmacología , Animales , Secuencia de Bases , Linfocitos T CD4-Positivos/metabolismo , Cartilla de ADN , Flavonoles , Inmunoglobulina E/sangre , Masculino , Ratones , Reacción en Cadena de la Polimerasa
16.
J Med Food ; 16(11): 1057-61, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24175656

RESUMEN

In this study, the protective effects of Brussels sprouts extract and its major constituents against oxidative stress-induced damages were investigated in rat pheochromocytoma cells and Institute of Cancer Research mice. The major constituents of Brussels sprouts (3,4',5,7-tetrahydroxyflavone (kaempferol), indole-3-carbinol, and phenethyl isothiocyanate) were selectively tested. Of these, the flavonoid compound, kaempferol exhibited the highest potency in radical scavenging activity (1,1-diphenyl-2-picryl hydrazyl assay and oxygen radical absorbance capacity assay) and was most protective against oxidative stress in neuronal cell assays (measurement of intracellular oxidative stress levels and cell viability). In mice, after 4 weeks of kaempferol administration, significant protection against amyloid beta (Aß) peptide-induced neurotoxicity was also observed, as assessed through the passive avoidance test. Taken together, the results suggest that Brussels sprouts could be protective against Aß-induced neurotoxicity, possibly due to the antioxidative capacity of its major constituent, kaempferol.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Antioxidantes/farmacología , Encéfalo/efectos de los fármacos , Brassica/química , Quempferoles/farmacología , Estrés Oxidativo/efectos de los fármacos , Enfermedad de Alzheimer/tratamiento farmacológico , Animales , Compuestos de Bifenilo/metabolismo , Encéfalo/citología , Encéfalo/metabolismo , Supervivencia Celular/efectos de los fármacos , Indoles/farmacología , Isotiocianatos/farmacología , Ratones , Ratones Endogámicos ICR , Fármacos Neuroprotectores/farmacología , Síndromes de Neurotoxicidad/tratamiento farmacológico , Síndromes de Neurotoxicidad/metabolismo , Células PC12 , Picratos/metabolismo , Extractos Vegetales/farmacología , Ratas
17.
J Med Food ; 16(11): 977-83, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24074359

RESUMEN

In this study, the protective effect of sweet potato extract against hydrogen peroxide-induced oxidative stress and cytotoxicity on the pheochromocytoma cell line (PC12) was investigated. The active component of the sweet potato extract was purified and determined to be 2,4-di-tert-butylphenol. The antioxidant capacity of 2,4-di-tert-butylphenol was measured by using 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid (ABTS) radical. To examine the effects of 2,4-di-tert-butylphenol on amyloid-beta peptide (Aß11₋42)-induced learning and memory impairment in mice, in vivo behavioral tests were performed. Administration of 2,4-di-tert-butylphenol increased alternation behavior in mice injected with Aß1₋42. These results suggest that sweet potato extract could be protective against Aß-induced neurotoxicity, possibly due to the antioxidative capacity of its constituent, 2,4-di-tert-butylphenol.


Asunto(s)
Antioxidantes/uso terapéutico , Trastornos del Conocimiento/tratamiento farmacológico , Ipomoea batatas/química , Lythraceae/química , Trastornos de la Memoria/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Fenoles/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/efectos adversos , Péptidos beta-Amiloides/metabolismo , Animales , Antioxidantes/farmacología , Benzotiazoles/metabolismo , Trastornos del Conocimiento/inducido químicamente , Trastornos del Conocimiento/metabolismo , Masculino , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/metabolismo , Ratones , Ratones Endogámicos ICR , Células PC12 , Fenoles/uso terapéutico , Fitoterapia , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ácidos Sulfónicos/metabolismo
18.
Toxicol Lett ; 223(2): 116-23, 2013 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-24070736

RESUMEN

Crotonaldehyde is a highly reactive aldehyde and a common environmental pollutant. It occurs in cigarette smoke and automobile exhaust, and is also endogenously generated by lipid peroxidation. Reactive aldehydes, such as crotonaldehyde, are considered to be important mediators of cell damage. Since endothelial apoptosis is considered to be the first step in the pathogenesis of cardiovascular disease, there have been many efforts to protect endothelial cell from oxidative stress. Heat shock protein 72 (HSP72) is a representative stress-inducible HSP70 family protein, and its synthesis is increased in response to multiple stressors. In the present study, we investigated the effect of crotonaldehyde on the up-regulation of HSP72 in human umbilical vein endothelial cells (HUVECs). Crotonaldehyde treatment caused nuclear accumulation of the heat shock transcription factor 1 (HSF1), leading to the induction of HSP72. Inhibition of the c-Jun N-terminal kinases (JNK) signaling pathways, reduction of intracellular calcium level and blocking of reactive oxygen species (ROS) generation resulted in significant blockage of crotonaldehyde-mediated HSP72 induction. In addition, HSP72 silencing by siRNA or calcium chelating by BAPTA/AM resulted in an obvious increase in the rate of apoptosis in crotonaldehyde-stimulated HUVECs. In summary, our data demonstrated that crotonaldehyde-induced HSP72 expression in HUVECs is mediated by the JNK-HSF1 pathway, and involves calcium ions and ROS, which is an adaptive response to oxidative stress caused by crotonaldehyde.


Asunto(s)
Aldehídos/farmacología , Apoptosis/efectos de los fármacos , Proteínas del Choque Térmico HSP72/metabolismo , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Ácido Egtácico/análogos & derivados , Ácido Egtácico/metabolismo , Contaminantes Ambientales/toxicidad , Proteínas del Choque Térmico HSP72/genética , Factores de Transcripción del Choque Térmico , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Humanos , Proteínas Quinasas JNK Activadas por Mitógenos/genética , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , ARN Interferente Pequeño , Especies Reactivas de Oxígeno , Transducción de Señal , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Regulación hacia Arriba
19.
J Med Food ; 16(9): 785-92, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24044488

RESUMEN

To find acetylcholinesterase (AChE) inhibitors for the prevention of neurological disorders, such as Alzheimer's disease, ethanol extracts of promising traditional edible Korean plants were tested. Among them, Rubus coreanus Miquel extract exhibited the most significant AChE inhibitory activity. The effect of R. coreanus extract on trimethyltin-induced memory impairment in mice was investigated using Y-maze and passive avoidance tests. Our results showed that administration of R. coreanus extract significantly improved alternation behavior and step-through latency. In addition, R. coreanus extract was sequentially fractionated, and the purified constituent was determined to be 3,4,5-trihydroxybenzoic acid.


Asunto(s)
Inhibidores de la Colinesterasa/administración & dosificación , Trastornos del Conocimiento/prevención & control , Demencia/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Rosaceae/química , Acetilcolinesterasa/metabolismo , Animales , Inhibidores de la Colinesterasa/química , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos del Conocimiento/enzimología , Trastornos del Conocimiento/psicología , Demencia/enzimología , Demencia/psicología , Modelos Animales de Enfermedad , Humanos , Masculino , Aprendizaje por Laberinto , Ratones , Ratones Endogámicos ICR , Fitoterapia , Extractos Vegetales/química
20.
Life Sci ; 93(15): 516-24, 2013 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-23933131

RESUMEN

AIMS: Atopic dermatitis (AD) is a chronic and relapsing inflammatory dermatitis characterized by pruritic and eczematous skin lesions. Here, we investigated the therapeutic effect of the fruit flavonoid naringenin on DNFB induced atopic dermatitis mice model. MAIN METHODS: AD-like skin lesion was induced by repetitive skin contact with DNFB in NC/Nga mice and the effects of the fruit flavonoid naringenin were evaluated on the basis of histopathological findings of skin, ear swelling and cytokine production of CD4(+)T cells. KEY FINDINGS: Intraperitoneal injection of naringenin for one week after DNFB challenge significantly lowered ear swelling and improved back skin lesions. In addition, naringenin significantly suppressed production of interferon-gamma (IFN-γ) by activated CD4(+) T cells and serum IgE level. Furthermore, naringenin reduced DNFB-induced infiltration of eosinophils, mast cells, CD4(+) T cells, and CD8(+) T cells in skin lesions. SIGNIFICANCE: Naringenin may suppress the development of AD-like skin lesions in DNFB-treated NC/Nga mice by reducing IFN-γ production of activated CD4(+) T cells, serum IgE levels and infiltration of immune cells to skin lesion.


Asunto(s)
Antiulcerosos/uso terapéutico , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dinitrofluorobenceno/efectos adversos , Flavanonas/uso terapéutico , Inflamación/tratamiento farmacológico , Animales , Linfocitos T CD4-Positivos/metabolismo , Citocinas/biosíntesis , Dermatitis Atópica/sangre , Dermatitis Atópica/patología , Oído/patología , Edema/tratamiento farmacológico , Inmunoglobulina E/sangre , Interferón gamma/biosíntesis , Masculino , Ratones , Piel/efectos de los fármacos , Piel/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...